The novel geriatric screening tool and retrospective validation in older patients with cancer

2014 ◽  
Vol 5 ◽  
pp. S16-S17
Author(s):  
J.W. Kim ◽  
S.-H. Kim ◽  
Y.J. Kim ◽  
K.-W. Lee ◽  
J.-O. Lee ◽  
...  
PLoS ONE ◽  
2015 ◽  
Vol 10 (9) ◽  
pp. e0138304 ◽  
Author(s):  
Jin Won Kim ◽  
Se-Hyun Kim ◽  
Yu Jung Kim ◽  
Keun-Wook Lee ◽  
Kwang-Il Kim ◽  
...  

2019 ◽  
Vol 10 (1) ◽  
pp. 159-163 ◽  
Author(s):  
Elise Deluche ◽  
Sophie Leobon ◽  
Francois Lamarche ◽  
Nicole Tubiana-Mathieu

Author(s):  
Cheryl P. Bruijnen ◽  
Anne Heijmer ◽  
Diny G. van Harten-Krouwel ◽  
Frederiek van den Bos ◽  
Remco de Bree ◽  
...  

2013 ◽  
Vol 24 (5) ◽  
pp. 1306-1312 ◽  
Author(s):  
C. Kenis ◽  
D. Bron ◽  
Y. Libert ◽  
L. Decoster ◽  
K. Van Puyvelde ◽  
...  

2021 ◽  
Vol 12 (8) ◽  
pp. S63-S64
Author(s):  
V. Depoorter ◽  
K. Vanschoenbeek ◽  
L. Decoster ◽  
H. De Schutter ◽  
P.R. Debruyne ◽  
...  

2019 ◽  
Vol 10 (2) ◽  
pp. 356-358 ◽  
Author(s):  
Lorenzo Dottorini ◽  
Laura Catena ◽  
Italo Sarno ◽  
Giandomenico Di Menna ◽  
Annamaria Marte ◽  
...  

2014 ◽  
Vol 32 (1) ◽  
pp. 19-26 ◽  
Author(s):  
Cindy Kenis ◽  
Lore Decoster ◽  
Katrien Van Puyvelde ◽  
Jacques De Grève ◽  
Godelieve Conings ◽  
...  

Purpose To compare the diagnostic characteristics of two geriatric screening tools (G8 and Flemish version of the Triage Risk Screening Tool [fTRST]) to identify patients with a geriatric risk profile and to evaluate their prognostic value for functional decline and overall survival (OS). Patients and Methods Patients ≥ 70 years old with a malignant tumor were included if a new cancer event occurred requiring treatment decision. Geriatric screening with G8 and fTRST (cutoff ≥ 1 [fTRST (1)] and ≥ 2 [fTRST (2)] evaluated) was performed in all patients, as well as a geriatric assessment (GA) evaluating social situation, functionality (activities of daily living [ADL] + instrumental activities of daily living [IADL]), cognition, depression, and nutrition. Functionality was re-evaluated 2 to 3 months after cancer treatment decision, and death rate was followed. Functional decline and OS were evaluated in relation to normal versus abnormal score on both screening tools. Results Nine hundred thirty-seven patients were included (October 2009 to July 2011). G8 and fTRST (1) showed high sensitivity (86.5% to 91.3%) and moderate negative predictive value (61.3% to 63.4%) to detect patients with a geriatric risk profile. G8 and fTRST (1) were strongly prognostic for functional decline on ADL and IADL, and G8, fTRST (1), and fTRST (2) were prognostic for OS (all P < .001). G8 had the strongest prognostic value for OS (hazard ratio for G8 normal v abnormal, 0.38; 95% CI, 0.27 to 0.52). Conclusion Both geriatric screening tools, G8 and fTRST, are simple and useful instruments in older patients with cancer for identifying patients with a geriatric risk profile and have a strong prognostic value for functional decline and OS.


2005 ◽  
Vol 3 (4) ◽  
pp. 572 ◽  

By 2030, researchers estimate that 20% of the U.S. population will be 65 years or older. More than 50% of all new cancers in the United States occur in this patient population. In addition, the increased incidence and prevalence of cancer in older patients and the increased lifespan of older adults mean that cancer in older individuals is becoming an increasingly common problem. Specific issues include geriatric screening and assessment, preventing or decreasing complications from therapy, accounting for disease-specific issues, and managing patients who cannot tolerate standard treatment. The NCCN Senior Adult Oncology Panel has developed guidelines for addressing these issues and for assessing the risks and benefits of treatment in older patients with cancer. For the most recent version of the guidelines, please visit NCCN.org


Sign in / Sign up

Export Citation Format

Share Document